Jacob Chacko
CIK 1608936 · PRESIDENT AND CEO · last filed 2026-06-18
Jacob Chacko is a PRESIDENT AND CEO who has filed 62 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for FDMT, was dated Jun 18, 2026. Across all open-market trades the lifetime net is −$3.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.93M
4
62
-$3.47M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FDMT | Director | 0 | $9.85 | $0 | -$100.3K | 7 | 2026-06-18 |
| ORIC | PRESIDENT AND CEO | 581,711 | $11.91 | $6.93M | -$3.49M | 33 | 2026-01-06 |
| Turning Point Therapeutics, Inc. (TPTX) Delisted | Director | — | $76.01 | — | $0 | 2 | 2020-06-17 |
| Ignyta, Inc. (RXDX) Delisted | Chief Financial Officer | 70,572 | $199.92 | $14.11M | $117.1K | 11 | 2018-01-05 |
Recent Filings
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-18 | FDMT | Grant (A) | — | $0 | EDGAR |
| 2026-01-06 | ORIC | Grant (A) | — | $0 | EDGAR |
| 2025-12-17 | ORIC | Mixed | +50,292 | -$302.4K | EDGAR |
| 2025-12-16 | ORIC | Notice (144) | −33,374 | -$302.4K | EDGAR |
| 2025-10-08 | ORIC | Sell (S) | −37,461 | -$461.5K | EDGAR |
| 2025-10-02 | ORIC | Sell (S) | −87,539 | -$1.05M | EDGAR |
| 2025-09-24 | ORIC | Sell (S) | −125,000 | -$1.35M | EDGAR |
| 2025-09-22 | ORIC | Notice (144) | −250,000 | -$2.62M | EDGAR |
| 2025-06-20 | FDMT | Grant (A) | — | $0 | EDGAR |
| 2025-01-03 | ORIC | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.